Tissue Regenix PLC’s (LON:TRX) chief executive Steve Cauldwell is to step down permanently after a recurrence of the illness that kept him away from January to June.
John Samuel will resume as executive chairman until a full-time chief executive is appointed while current COO Gareth Jones will become interim- CEO.
Cauldwell said: “ The company is at such an exciting point of commercial and operational inflection and I remain committed to being available as an adviser and mentor wherever possible."